Bringing the fundamentals into focus…
Back to Olema Pharmaceuticals, Inc.
How Olema Pharmaceuticals, Inc. stacks up
OLMA · against 552 other Healthcare companies listed in US-listed
Overall
31/ 100
Near the bottom of its peers.
Ranked #415 of 553 · scores higher than 22% of peers
Bars: peers in each 10-point band of the overall score142 peers with an overall score of 30–39, including OLMA · Click a bar to see the companies
The four scores behind it
Overall = average of valuation, growth, profitability and safety percentile (categories without data are skipped)Ranking by overall score
Top 5 and the companies ranked around OLMA| Rank | Company | Market cap | Overall | Valuation | Growth | Profitability | Risk |
|---|---|---|---|---|---|---|---|
| 1 | 595M USD | 97 | 96 | 98 | 99 | 0 / 2 | |
| 1 | 261M USD | 97 | 93 | — | 98 | 0 / 2 | |
| 3 | 2.1B USD | 96 | 96 | 99 | 93 | 0 / 2 | |
| 4 | 1.5B USD | 93 | 94 | 91 | 93 | 0 / 2 | |
| 5 | 609M USD | 91 | 95 | 99 | 99 | 0 / 2 | |
| 415 | 1.8B USD | 31 | 8 | 77 | 29 | 2 / 2 | |
| 415 | 8.8B USD | 31 | 8 | 99 | 10 | 2 / 2 | |
| 415 | 1.1B USD | 31 | 42 | — | 40 | 2 / 2 | |
| 415 | 107M USD | 31 | 75 | — | 15 | 2 / 2 | |
| 415 | 643M USD | 31 | 8 | — | 16 | 0 / 2 | |
| 415 | 124M USD | 31 | 8 | 81 | 22 | 2 / 2 | |
| 415 | 14.0B USD | 31 | 8 | 88 | 25 | 2 / 2 | |
| 415 | 89M USD | 31 | 33 | — | 2 | 1 / 2 | |
| 415 | 513M USD | 31 | 8 | 85 | 24 | 2 / 2 |
Scores are sector-relative percentiles from the latest snapshot, always calculated against the whole sector: narrowing the comparison group changes who you compare with, not the scores. Missing metrics are left out and the remaining weights rescaled. How we score